You just read:

Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

News provided by

Boehringer Ingelheim (Canada) Ltd.

Feb 12, 2019, 08:00 ET